Medicare Enrolled
Dr. Anthony Licata, M.D.
Cardiovascular Disease · Lancaster, PA
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Licata from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Licata?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Licata
Dr. Anthony Licata is a cardiovascular disease specialist in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Licata performed 2,634 Medicare services across 2,237 unique beneficiaries.
Between the years covered by Open Payments, Dr. Licata received a total of $6,992 from 33 pharmaceutical and/or device companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Licata is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 29% volume in PA
$6,992 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,634
Medicare services
Top 29% in PA for cardiovascular disease
2,237
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~132 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
562 | $9 | $53 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
234 | $127 | $246 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
217 | $6 | $18 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
127 | $12 | $68 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
100 | $86 | $181 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
86 | $16 | $72 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
86 | $18 | $58 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
86 | $25 | $86 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
80 | $43 | $88 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
79 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 79 | $146 | $351 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
69 | $10 | $32 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
63 | $18 | $58 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
62 | $16 | $49 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $60 | $143 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
52 | $91 | $206 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
48 | $131 | $470 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $133 | $401 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
40 | $19 | $139 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
38 | $51 | $127 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
38 | $34 | $90 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
30 | $81 | $245 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
26 | $57 | $187 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $96 | $271 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
24 | $114 | $388 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
24 | $111 | $244 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
22 | $9 | $30 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
20 | $20 | $56 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
19 | $49 | $212 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
19 | $5 | $17 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
18 | $13 | $41 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
17 | $47 | $138 |
| Ultrasound of heart with contrast injection An ultrasound of the heart is performed while injecting an X-ray contrast agent to improve the clarity of the images. |
17 | $24 | $73 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
16 | $82 | $437 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
16 | $35 | $117 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
13 | $43 | $321 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
13 | $9 | $30 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
13 | $18 | $52 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
13 | $14 | $26 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
12 | $14 | $56 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
12 | $19 | $54 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
11 | $13 | $96 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.5% high complexity
20.2% medium
64.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,992
Total received (2018-2024)
Avg $999/year across 7 years
Top 27% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
303
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,992 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$405
2023
$508
2022
$337
2021
$454
2020
$211
2019
$3,256
2018
$1,822
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$99
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$85
Medtronic, Inc.
$60
ABIOMED
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Amgen Inc.
$35
Novartis Pharmaceuticals Corporation
$28
PFIZER INC.
$15
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,957
Novartis Pharmaceuticals Corporation
$809
Janssen Pharmaceuticals, Inc
$430
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$316
Boehringer Ingelheim Pharmaceuticals, Inc.
$285
PFIZER INC.
$279
Amgen Inc.
$259
AstraZeneca Pharmaceuticals LP
$251
Boston Scientific Corporation
$246
SANOFI-AVENTIS U.S. LLC
$229
E.R. Squibb & Sons, L.L.C.
$217
PORTOLA PHARMACEUTICALS, INC.
$211
Astellas Pharma US Inc
$193
Actelion Pharmaceuticals US, Inc.
$165
ABIOMED
$157
Bayer HealthCare Pharmaceuticals Inc.
$157
Lantheus Medical Imaging, Inc.
$130
Medtronic, Inc.
$111
United Therapeutics Corporation
$92
Amarin Pharma Inc.
$71
Regeneron Healthcare Solutions, Inc.
$51
Daiichi Sankyo Inc.
$47
Lundbeck LLC
$46
Impulse Dynamics (USA) Inc.
$45
Chiesi USA, Inc.
$45
Relypsa, Inc.
$39
Kowa Pharmaceuticals America, Inc.
$38
SCPHARMACEUTICALS INC.
$34
Akcea Therapeutics, Inc.
$23
Lexicon Pharmaceuticals, Inc.
$18
Philips Electronics North America Corporation
$17
Otsuka America Pharmaceutical, Inc.
$15
GE HEALTHCARE
$9
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
(6578) Visions 018 · ANDEXXA · AVEIR · Adempas · BEVYXXA · BRILINTA · CAMZYOS · CHANTIX · CLEVIPREX · Corlanor · DEFINITY · DIAMONDBACK PERIPHERAL · ELIQUIS · ENTRESTO · EXPORT AP · FARXIGA · FFRANGIO · FUROSCIX · GENERAL PAIN MANAGEMENT · INJECTAFER · Impella · Inpefa · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MULTAQ · Mitra Clip system · MitraClip System · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · SAMSCA · SYMPLICITY G3 · TEGSEDI · TELESCOPE · TYVASO · VIAGRA · VYNDAQEL · Vascepa · Veltassa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
104
Per 100K population
18.7
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Licata is an electrophysiology & remote specialist, with above-average Medicare volume (top 29% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Licata experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Licata performed 562 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Licata receive payments from pharmaceutical companies?
Yes. Dr. Licata received a total of $6,992 from 33 companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Licata's costs compare to other cardiologists in Lancaster?
Dr. Licata's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Licata) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Lancaster
Browse cardiologists in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology